Literature DB >> 24808364

CD8 T cell-evasive functions of human cytomegalovirus display pervasive MHC allele specificity, complementarity, and cooperativity.

Stefanie Ameres1, Katrin Besold2, Bodo Plachter2, Andreas Moosmann3.   

Abstract

Immunoevasive proteins ("evasins") of human CMV (HCMV) modulate stability and localization of MHC class I (MHC I) molecules, and their supply of antigenic peptides. However, it is largely unknown to what extent these evasins interfere with recognition by virus-specific CD8 T cells. We analyzed the recognition of HCMV-infected cells by a panel of CD8 T cells restricted through one of nine different MHC I allotypes. We employed a set of HCMV mutants deleted for three or all four of the MHC I modulatory genes US2, US3, US6, and US11. We found that different HCMV evasins exhibited different allotype-specific patterns of interference with CD8 T cell recognition of infected cells. In contrast, recognition of different epitopes presented by the same given MHC I allotype was uniformly reduced. For some allotypes, single evasins largely abolished T cell recognition; for others, a concerted action of evasins was required to abrogate recognition. In infected cells whose Ag presentation efficiency had been enhanced by IFN-γ pretreatment, HCMV evasins cooperatively impared T cell recognition for several different MHC I allotypes. T cell recognition and MHC I surface expression under influence of evasins were only partially congruent, underscoring the necessity to probe HCMV immunomodulation using specific T cells. We conclude that the CD8 T cell evasins of HCMV display MHC I allotype specificity, complementarity, and cooperativity.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24808364     DOI: 10.4049/jimmunol.1302281

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells.

Authors:  R J O'Reilly; G Koehne; A N Hasan; E Doubrovina; S Prockop
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

2.  Cytomegalovirus inhibition of extrinsic apoptosis determines fitness and resistance to cytotoxic CD8 T cells.

Authors:  M Zeeshan Chaudhry; Rosaely Casalegno-Garduno; Katarzyna M Sitnik; Bahram Kasmapour; Ann-Kathrin Pulm; Ilija Brizic; Britta Eiz-Vesper; Andreas Moosmann; Stipan Jonjic; Edward S Mocarski; Luka Cicin-Sain
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-22       Impact factor: 11.205

3.  Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia.

Authors:  Guenther Koehne; Aisha Hasan; Ekaterina Doubrovina; Susan Prockop; Eleanor Tyler; Gloria Wasilewski; Richard J O'Reilly
Journal:  Biol Blood Marrow Transplant       Date:  2015-05-29       Impact factor: 5.742

Review 4.  Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections.

Authors:  R J O'Reilly; S Prockop; A N Hasan; G Koehne; E Doubrovina
Journal:  Bone Marrow Transplant       Date:  2016-04-04       Impact factor: 5.483

5.  Expression of the human cytomegalovirus UL11 glycoprotein in viral infection and evaluation of its effect on virus-specific CD8 T cells.

Authors:  Ildar Gabaev; Endrit Elbasani; Stefanie Ameres; Lars Steinbrück; Richard Stanton; Marius Döring; Tihana Lenac Rovis; Ulrich Kalinke; Stipan Jonjic; Andreas Moosmann; Martin Messerle
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

Review 6.  Therapeutic advantages provided by banked virus-specific T-cells of defined HLA-restriction.

Authors:  Richard J O'Reilly; Susan Prockop; Aisha Hasan; Ekaterina Doubrovina
Journal:  Bone Marrow Transplant       Date:  2019-08       Impact factor: 5.483

7.  Characterization of the HCMV-Specific CD4 T Cell Responses that Are Associated with Protective Immunity.

Authors:  Marie Wunsch; Wenji Zhang; Jodi Hanson; Richard Caspell; Alexey Y Karulin; Mascha S Recks; Stefanie Kuerten; Srividya Sundararaman; Paul V Lehmann
Journal:  Viruses       Date:  2015-08-06       Impact factor: 5.048

8.  A Diverse Repertoire of CD4 T Cells Targets the Immediate-Early 1 Protein of Human Cytomegalovirus.

Authors:  Stefanie Ameres; Xiaoling Liang; Martina Wiesner; Josef Mautner; Andreas Moosmann
Journal:  Front Immunol       Date:  2015-11-25       Impact factor: 7.561

9.  Targeting the latent human cytomegalovirus reservoir for T-cell-mediated killing with virus-specific nanobodies.

Authors:  Timo W M De Groof; Elizabeth G Elder; Eleanor Y Lim; Raimond Heukers; Nick D Bergkamp; Ian J Groves; Mark Wills; John H Sinclair; Martine J Smit
Journal:  Nat Commun       Date:  2021-07-21       Impact factor: 14.919

10.  Cytomegalovirus-Infected Cells Resist T Cell Mediated Killing in an HLA-Recognition Independent Manner.

Authors:  Julia Proff; Christian Walterskirchen; Charlotte Brey; Rene Geyeregger; Florian Full; Armin Ensser; Manfred Lehner; Wolfgang Holter
Journal:  Front Microbiol       Date:  2016-06-09       Impact factor: 6.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.